, 42 years old
Location of patient: Zagreb, Croatia
Health condition: Breast cancer
Hospital: MD Anderson Cancer Center, Spain
Type of treatment: Surgery
Cost of treatment: €97,000
Uncertain and concerned about her diagnosis, Mihaela went to a private practice and on the same day a biopsy was performed. Mihaela was diagnosed with invasive breast cancer and advised to have surgery to remove it. She was put on a waiting list for the surgical procedure.
Mihaela had access to Further's policy through her employer, providing access to the best international medical treatment. Mihaela was immediately provided access to the international centres of excellence renowned for treating her condition.
Since Mihaela’s preferred treatment destinations were Spain and Germany, our team recommended leading international hospitals located in these countries.
Mihaela chose a hospital specialising in the treatment of breast cancer – the MD Anderson Cancer Center in Madrid - which is a part of the MD Anderson group, a renowned U.S. based group of hospitals noted for clinical excellence.
She underwent testing and consultations with her international doctors and a treatment plan was set for Mihaela. She required a radical mastectomy after which her doctor recommended chemotherapy. The mastectomy and reconstruction surgery were very successful.
Our team also arranged additional tests following her surgery, such as BRCA gene and Mammaprint test, which found that Mihaela had a high risk of the cancer recurring and was prescribed hormonotherapy.
All the costs and arrangements for the surgery, chemotherapy, hormonotherapy, genetic testing, travel and accommodation were all covered by the policy that Mihaela obtained as an employee benefit from her employer.
She is now home and feeling like herself again. She is still being supported both by her doctors in Madrid and the Further team, and will return for follow-up in 3 months time, a service that is also covered by the policy.